Page last updated: 2024-11-04

4-carboxyphenylglycine and Vasospasm, Intracranial

4-carboxyphenylglycine has been researched along with Vasospasm, Intracranial in 1 studies

4-carboxyphenylglycine: RN given for (+-)-isomer; RN for cpd without isomeric designation not available 3/93; glutamate receptor antagonist

Vasospasm, Intracranial: Constriction of arteries in the SKULL due to sudden, sharp, and often persistent smooth muscle contraction in blood vessels. Intracranial vasospasm results in reduced vessel lumen caliber, restricted blood flow to the brain, and BRAIN ISCHEMIA that may lead to hypoxic-ischemic brain injury (HYPOXIA-ISCHEMIA, BRAIN).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garzon-Muvdi, T1
Pradilla, G1
Ruzevick, JJ1
Bender, M1
Edwards, L1
Grossman, R1
Zhao, M1
Rudek, MA1
Riggins, G1
Levy, A1
Tamargo, RJ1

Other Studies

1 other study available for 4-carboxyphenylglycine and Vasospasm, Intracranial

ArticleYear
A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].
    Neurosurgery, 2013, Volume: 73, Issue:4

    Topics: Animals; Benzoates; Blotting, Western; Cell Adhesion Molecules; Chromatography, High Pressure Liquid

2013